It is known for its potential biological and therapeutic effects (31), largely attributed to the quality and concentration of these bioactive components (32)
[68] [45] Ligands [edit] Agonists [edit] Mixed [edit] Antagonists [edit] Steroidal antiandrogens (e.g., cyproterone acetate, chlormadinone acetate, spironolactone, oxendolone) Nonsteroidal antiandrogens (e.g., flutamide, nilutamide, bicalutamide, enzalutamide, apalutamide, RU-58841) N-Terminal domain antiandrogens (e.g., bisphenol A, EPI-001, ralaniten, JN compounds) [70] As a drug target [edit] The AR is an important therapeutic target in prostate cancer
Hewlett-Packard made its first acquirement in 1958 when it acquired the F Mosley company from California
BPC-157 is thought to stabilize vascular growth, while TB-500 may enhance cell migration toward the site of repair